These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6966316)

  • 1. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies of natural killer cell function in Chediak-Higashi patients.
    Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
    Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
    Haliotis T; Roder J; Klein M; Ortaldo J; Fauci AS; Herberman RB
    J Exp Med; 1980 May; 151(5):1039-48. PubMed ID: 6154765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new immunodeficiency disorder in humans involving NK cells.
    Roder JC; Haliotis T; Klein M; Korec S; Jett JR; Ortaldo J; Heberman RB; Katz P; Fauci AS
    Nature; 1980 Apr; 284(5756):553-5. PubMed ID: 6445041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A; Herberman RB; Holden HT
    J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2.
    Cifaldi L; Pinto RM; Rana I; Caniglia M; Angioni A; Petrocchi S; Cancrini C; Cursi L; Palumbo G; Zingoni A; Gismondi A; Rossi P; Santoni A; Cerboni C
    Immunol Lett; 2016 Dec; 180():46-53. PubMed ID: 27816481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
    Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
    Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
    Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
    J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
    Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
    J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment.
    Roder JC; Todd RF; Rubin P; Haliotis T; Helfand SL; Werkmeister J; Pross HF; Boxer LA; Schlossman SF; Fauci AS
    Clin Exp Immunol; 1983 Feb; 51(2):359-68. PubMed ID: 6839545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
    Brahmi Z
    Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-delta T cells in Chediak-Higashi syndrome.
    Holcombe RF; van de Griend R; Ang SL; Bolhuis RL; Seidman JG
    Acta Haematol; 1990; 83(4):193-7. PubMed ID: 2115716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome.
    Argov S; Johnson DR; Collins M; Koren HS; Lipscomb H; Purtilo DT
    Cell Immunol; 1986 Jun; 100(1):1-9. PubMed ID: 3742598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.